Showing results (131-140 of 1,698) with videos related to
Sort By:
Pageof 170
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|July 1, 1992
[Effects of harman and norharman on aflatoxin B1 and aminopyrine metabolism by phenobarbital and 3-methylcholanthrene-induced rat liver microsomes]D X LinZhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 1, 1993
[F-actin aggregates and aberrations of cytoskeletal organization of microfilaments and microtubules in human breast carcinoma cells]Z X LinZhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|February 1, 1989
[Analysis on distribution of epidemic hemorrhagic fever in different area]F X LinCancer Research|August 1, 1988
Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma modelJ L Mohler, A W Partin, J T Isaacs, et al.Cancer Research|November 1, 1978
Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-ATJ T Isaacs, W D Heston, R M Weissman, et al.Genomics|April 1, 1997
Genomic organization of the human KAI1 metastasis-suppressor geneJ T Dong, W B Isaacs, J C Barrett, et al.The Prostate|July 1, 1996
Development of a high-efficiency method for gene marking of Dunning prostate cancer cell lines with the enzyme beta-galactosidaseC W Rinker-Schaeffer, J F Wharam, J Simons, et al.The Journal of Urology|April 1, 1984
The use of multiple variables to predict response to endocrine therapy in carcinoma of the prostate: a preliminary reportC B Brendler, J T Isaacs, A L Follansbee, et al.The Prostate|January 1, 1992
Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657J C Lamb, M A Levy, R K Johnson, et al.Cancer Research|June 15, 1992
Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468D K Armstrong, J T Isaacs, Y L Ottaviano, et al.Pageof 170